Dr. Silverman currently works at the David Geffen School of Medicine at UCLA, where he has a faculty appointment as a Professor of Clinical Obstetrics and Gynecology, and serves as the director of the Maternal-Fetal Medicine fellowship program. In addition to his clinical and teaching responsibilities, he is also the director of the department’s new Infectious Diseases in Pregnancy Program. In that capacity, he is working with both the adult and pediatric ID divisions, as well as the department of microbiology, to develop a multidisciplinary program to develop educational, research, and clinical care focuses in this area.
Dr. Silverman has authored over 50 peer-reviewed manuscripts, 20 textbook chapters, and lectured widely, with particular interests in obstetric infectious diseases, recurrent pregnancy loss and thrombophilias, and prenatal diagnosis. Nationally, Dr. Silverman has served 2 terms on the Executive Council of the Infectious Diseases Society for Obstetrics and Gynecology. He served a 5-year term on ACOG’s Practice Bulletin Committee for Obstetrics, serving as committee chair from 2011-2013, and is a named primary or senior author on 4 current Bulletins. He has also served on the Publications Committee for the Society for Maternal-Fetal Medicine (SMFM), was an elected member of its Board of Directors, and worked for 4 years as the Society’s liaison member to ACOG’s Committee on Ethics. He was most recently a member of ACOG’s Clinical Consensus – Obstetrics Committee (formerly the Committee on Obstetric Practice) for 4 years, and co-authored the most recent guidelines on prevention of perinatal group B strep disease in that role. Until earlier this year, he served as ACOG’s liaison to AAP’s Committee on Infectious Diseases, and has recently been asked to rejoin ACOG’s Expert Work Group on vaccines and emerging infections.
Medical Board Certifications
Areas of Focus
1. VanHise K, Dellapiana G, Silverman NS. Intra-amniotic instillation of indocyanine green in uncertain cases of preterm rupture of membranes. Amer J Obstet Gynecol MFM 2022 Apr 7:100638.
2. Gong P, Wallerstein R, Silverman NS, Pelletier M, Fissell K. Challenges in genetic evaluation for Congenital Anomalies of the Kidneys and Urinary Tract (CAKUT) spectrum in pregnancy. Case Reports Perinatal Med 2022; 11(1): 20210063.
3. Afshar Y, Silverman NS, Han CS, Platt LD. Clinical guidance and perinatal care in the era of coronavirus disease 2019 (CoVID-19). J Perinatal Med 2020; 48: 925-30.
4. Mei JY, Deshmukh U, Negi M, Campbell K, Paidas MJ, Platt LD, Silverman NS, Han CS. May-Thurner syndrome in pregnancy: A multi-institutional case series and review of the literature. Amer J Obstet Gynecol MFM 2020 Oct 3:100240.
5. Turrentine MA, King T, Silverman NS. Penicillin allergy in pregnancy: Moving from “rash” decisions to accurate diagnosis. Clinical Expert Series. Obstet Gynecol 2020;135: 401-8.
6. King T, Silverman NS, Turrentine M, ACOG Committee on Obstetric Practice. Prevention of neonatal early-onset group B streptococcal disease. ACOG Committee Opinion No. 797. American College of Obstetricians and Gynecologists. Obstet Gynecol 2020;135: e51-72.
7. Silverman NS. Hepatitis B virus screening in pregnant women: the new USPSTF recommendations (editorial). JAMA 2019: 322: 312-14.
8. Rao RR, Gaw SL, Han CS, Platt LD, Silverman NS. Zika risk and pregnancy in clinical practice: Ongoing experience as the outbreak evolves. Obstet Gynecol 2017;129:1098-103.
9. James AH, Bates SM, Bauer KA, Branch W, Mann K, Paidas M, Silverman N, Konkle BA. Management of hereditary antithrombin deficiency in pregnancy. Thrombosis Research 2017; 157: 41-5.
10. Harris LH, Silverman NS, Marshall MF. The paradigm of the paradox: Women, pregnant women, and the unequal burdens of the Zika epidemic. Am J Bioethics 2016; 16: 5, 1-4.